Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor
about
Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIVAssessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3Flexible Cyclic Ethers/Polyethers as Novel P2-Ligands for HIV-1 Protease Inhibitors: Design, Synthesis, Biological Evaluation, and Protein−Ligand X-ray Studies †Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV proteaseBiophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix proteinStructural evidence of intramolecular propeptide inhibition of the aspzincin metalloendopeptidase AsaP1Evidence that the Bacillus subtilis SpoIIGA protein is a novel type of signal-transducing aspartic proteaseAlteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV.Human immunodeficiency virus and AIDS: insights from animal lentivirusesHarnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease.Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease.Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteasesAltered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAVMolecular mechanisms of FIV infection.Role of darunavir in the management of HIV infection.The molecular biology of feline immunodeficiency virus (FIV).Enhancing protein backbone binding--a fruitful concept for combating drug-resistant HIV.Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDSDesign and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants.Evolutionary analysis of HIV-1 protease inhibitors: Methods for design of inhibitors that evade resistance.Formation of RNA Granule-Derived Capsid Assembly Intermediates Appears To Be Conserved between Human Immunodeficiency Virus Type 1 and the Nonprimate Lentivirus Feline Immunodeficiency Virus.
P2860
Q24681002-3BDB13BD-9C33-4AE7-BEF1-FD8C2EC33069Q24801797-63291CF1-B4E0-473D-B02F-9F6617666A4FQ27641090-3999C1DA-2E27-4BFE-AAB6-E29B4E8787ACQ27652070-13BE9873-F00C-44F1-91C7-73F4BC5D144EQ27668150-CE7FB20A-6D00-454C-8D00-9ED8A9FD17FDQ27678797-73E14098-B975-4F2E-B329-24660CA16B14Q27727696-7E5D1C03-6C0B-4953-A12E-D7A79EE71B1EQ28489003-4135DDB8-B460-4DAC-9E37-43A2F93EEAA1Q30860360-A3D07B64-3DBA-4E42-9FB3-87646824EA25Q33786404-8C3BE3EE-D1FB-48C2-9093-8E04C612FB42Q33809273-1E9ED954-EBE1-43C1-8880-020D2C6A97F6Q33870886-E26C6B3D-A2BF-4547-943A-C4581465F679Q33990752-F9D4D1A6-878C-4B06-824D-BC89F4F43FA9Q35020110-25239D0B-7090-4A8C-8588-1F24679AF1DDQ35024024-79CCBB22-60C3-4271-A5BE-9FB74F3AB93CQ36280729-F0D48D8C-1DFF-42D8-9933-60234650C0DCQ36692802-38FD8817-74AF-41C7-8158-A10B182B1F5DQ37957871-C184D4DE-2CCA-4688-93A3-A9A9E4552117Q37967732-6448F70B-8A7B-4660-9921-C53E015EA337Q37980084-E86EDE4E-EDBC-411C-94D6-CF028DB67E29Q38708006-BF01541D-D5ED-47F1-890D-ABD689CCAB79Q40238681-F5E66178-917B-43B2-8C56-34E2B3B2346FQ43994824-CDEEF0FB-11E6-4074-B067-6D293EE1139AQ52375200-72F767F3-9C77-4790-8471-BBDB2904AC4F
P2860
Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Crystal structures of the inac ...... h a substrate and an inhibitor
@ast
Crystal structures of the inac ...... h a substrate and an inhibitor
@en
Crystal structures of the inac ...... h a substrate and an inhibitor
@nl
type
label
Crystal structures of the inac ...... h a substrate and an inhibitor
@ast
Crystal structures of the inac ...... h a substrate and an inhibitor
@en
Crystal structures of the inac ...... h a substrate and an inhibitor
@nl
prefLabel
Crystal structures of the inac ...... h a substrate and an inhibitor
@ast
Crystal structures of the inac ...... h a substrate and an inhibitor
@en
Crystal structures of the inac ...... h a substrate and an inhibitor
@nl
P2093
P356
P1433
P1476
Crystal structures of the inac ...... h a substrate and an inhibitor
@en
P2093
Gustchina A
Lubkowski J
Schalk-Hihi C
Wlodawer A
P304
10696-10708
P356
10.1021/BI9707436
P407
P577
1997-09-01T00:00:00Z